Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor de Ledinghen

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|March 9, 2017
Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access CohortKarine Lacombe, Hélène Fontaine, Catherine Dhiver, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 28, 2016
Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantationJérôme Dumortier, Vincent Leroy, Christophe Duvoux, et al.
Clinical and Molecular Hepatology|May 20, 2026
The Natural History and Individualized Prediction of Liver Stiffness-Based Fibrosis Risk in MASLDYu Shi, Ruoqi Zhou, Seung Up Kim, et al.
The Lancet. Infectious Diseases|March 17, 2015
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)Marc Bourlière, Jean-Pierre Bronowicki, Victor de Ledinghen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2023
Prognostic value of non-invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV-infected patientsAmine Benmassaoud, Juan Macias, Adèle Delamarre, et al.
Plos One|January 26, 2019
Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort studySarah Shili-Masmoudi, Philippe Sogni, Victor de Ledinghen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2025
Relink Programmes: Impact of Reengagement on Linkage to Care Across 82 006 People With Hepatitis CMaria Buti, Joost P H Drenth, Manuel Mendizabal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 16, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysisJörn M Schattenberg, Jeffrey V Lazarus, Philip N Newsome, et al.
JHEP Reports : Innovation in Hepatology|August 4, 2023
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver diseaseGrazia Pennisi, Marco Enea, Mauro Viganò, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2017
Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT studySébastien Dharancy, Audrey Coilly, Claire Fougerou-Leurent, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
Journal of Acquired Immune Deficiency Syndromes (1999)|March 9, 2017
Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access CohortKarine Lacombe, Hélène Fontaine, Catherine Dhiver, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 28, 2016
Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantationJérôme Dumortier, Vincent Leroy, Christophe Duvoux, et al.
Clinical and Molecular Hepatology|May 20, 2026
The Natural History and Individualized Prediction of Liver Stiffness-Based Fibrosis Risk in MASLDYu Shi, Ruoqi Zhou, Seung Up Kim, et al.
The Lancet. Infectious Diseases|March 17, 2015
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)Marc Bourlière, Jean-Pierre Bronowicki, Victor de Ledinghen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2023
Prognostic value of non-invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV-infected patientsAmine Benmassaoud, Juan Macias, Adèle Delamarre, et al.
Plos One|January 26, 2019
Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort studySarah Shili-Masmoudi, Philippe Sogni, Victor de Ledinghen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2025
Relink Programmes: Impact of Reengagement on Linkage to Care Across 82 006 People With Hepatitis CMaria Buti, Joost P H Drenth, Manuel Mendizabal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 16, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysisJörn M Schattenberg, Jeffrey V Lazarus, Philip N Newsome, et al.
JHEP Reports : Innovation in Hepatology|August 4, 2023
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver diseaseGrazia Pennisi, Marco Enea, Mauro Viganò, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2017
Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT studySébastien Dharancy, Audrey Coilly, Claire Fougerou-Leurent, et al.
Pageof 18